Long term cultured hl-60 cells are intrinsically resistant to Ara-C through high CDA activity

Frontiers in Bioscience

Volumn 17, Issue 2, 2012, Pages 569-574

  Tang, Jinqing ^a   Xie, Xiaotian ^a   Zhang, Xiaoping ^a   Qiao, Xiaohong ^a   Jiang, Shayi ^a   Shi, Wei ^a   Shao, Yuexia ^a   Zhou, Xiaoxun ^a  

^a TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

CDA activity; Cytarabine; Hl 60; Leukemic cells

Indexed keywords

ARA;

EID: 84860277532     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/3944     Document Type: Article

References (30)

1. A. Newland: Progress in the treatment of acute myeloid leukemia in adults. Int J Hematol, 76 (Suppl. 1):253-8 (2002).
2. E. F. Winton, A. A. Langston: Update in acute leukemia 2003: a risk adapted approach to acute myeloblastic leukaemia in adults. Semin Oncol, 31 (2 Suppl. 4):80-6 (2004). (Pubitemid 38609798)
3. F. Ferrara: Unanswered questions in acute myeloid leukaemia. Lancet Oncol, 5:443-50 (2004). (Pubitemid 38885651)
4. J. F. Bishop, J. P. Matthews, G. A. Young, J. Szer, A. Gillett, D. Joshua, K. Bradstock, A. Enno, M. M. Wolf, R. Fox, R. Cobcroft, R. Herrmann, M. Van Der Weyden, R. M. Lowenthal, F. Page, O. M. Garson, S. Juneja: A randomized study of highdose cytarabine in induction in acute myeloid leukemia. Blood, 87:1710-1717 (1996). (Pubitemid 26068888)
5. R. L. Momparler, G. A. Fischer: Mammalian deoxynucleoside kinase. I. Deoxycytidine kinase: purification, properties, and kinetic studies with cytosine arabinoside. J Biol Chem, 243:4298-4304 (1968).
6. P. G. Plagemann, R. Marz, R. M. Wohlhueter: Transport and metabolism of deoxycytidine and 1-beta-Darabinofuranosylcytosine into cultured Novikoff rat hepatoma cells, relationship to phosphorylation, and regulation of triphosphate synthesis. Cancer Res, 38:978- 989 (1978). (Pubitemid 8393766)
7. J. J. Furth, S. S. Cohen: Inhibition of mammalian DNA polymerase by the 50-triphosphate of 1-b-Darabinofuranosylcytosine and the 50-triphosphate of 9-b-Darabinofuranosyladenine. Cancer Res, 28: 2061-7 (1968).
8. A. Inagaki, T. Nakamura, G. Wakisaka: Studies on the mechanism of action of 1-b-D-arabinofuranosylcytosine as an inhibitor of DNA synthesis in human leukemic leukocytes. Cancer Res, 29: 2169-76 (1969).
9. D. W. Kufe, P. P. Major, E. M. Egan, G.P. Beardsley: Correlation of cytotoxicity with incorporation of ara-C into DNA. J Biol Chem, 255:8997-9990 (1980).
10. P. P. Major, E. M. Egan, G. P. Beardsley, M. D. Minden, D.W. Kufe: Lethality of human myeloblasts correlates with the incorporation of arabinofuranosylcytosine into DNA. Proc Natl Acad Sci USA, 78:3235-9 (1981). (Pubitemid 11032022)
11. G. W. Camiener: Studies of the enzymatic deamination of aracytidine. V. inhibition in vitro and in vivo by tetrahydrouridine and other reduced pyrimidine nucleosides. Biochem Pharmacol, 17 (9):1981-91 (1968).
12. E. Estey, W. Plunkett, D. Dixon, M. Keating, K. McCredie, E. J Freireich: Variables predicting response to high dose cytosine arabinoside therapy in patients with refractory acute leukemia. Leukemia, 1:580-583 (1987). (Pubitemid 18005688)
13. Y. M. Rustum, H. D. Preisler: Correlation between leukemic cell retention of 1-beta-Darabinofuranosylcytosine 5- triphosphate and response to therapy. Cancer Res, 39:42-49 (1979). (Pubitemid 9090410)
14. C. M. Galmarini, X. Thomas, F. Calvo, et al: In vivo mechanisms of resistance to cytarabine in acute myeloid leukaemia. Br J Haematol, 117: 860-868 (2002). (Pubitemid 34639247)
15. C. M. Galmarini, X. Thomas, F. Calvo, et al: Potential mechanisms of resistance to cytarabine in AML patients. Leuk Res, 26: 621-629 (2002). (Pubitemid 34465699)
16. J. K. Schroder, C. Kirch, S. Seeber and Schutte J.: Structural and functional analysis of the cytidine deaminase gene in patients with acute myeloid leukaemia. Br J Haematol, 103: 1096-1103 (1998). (Pubitemid 29012650)
17. C. E. Cass, J. D. Young and S. A. Baldwin: Recent advances in the molecular biology of nucleoside transporters of mammalian cells. Biochem Cell Biol, 76: 761-770 (1998). (Pubitemid 29318172)
18. J. C. White, J. P. Rathmell and R. L. Cappizi: Membrane transport influences the rate of accumulation of cytosine arabinoside in human leukemia cells. J Clin Invest, 79: 380-387 (1987). (Pubitemid 17009669)
19. S. Yamamoto, T. Yamauchi, S. Kishi, T. Ueda: The combination effects of cytarabine with fludarabine on cytarabine-resistant leukemia. Gout Nucleic Acid Metabol, 29:61 (2005).
20. S. Yamamoto, T. Yamauchi, Y. Kawai, H. Takemura, S. Kishi, A. Yoshida, et al: Fludarabine-mediated circumvention of cytarabine resistance is associated with fludarabine triphosphate accumulation in cytarabineresistant leukemic cells. Int J Hematol, 85:108-15 (2007). (Pubitemid 46365546)
21. T. Yamauchi, T. Ueda, T. Nakamura: A new sensitive method for determination of intracellular 1-b-Darabinofuranosylcytosine 50-triphosphate content in human materials in vivo. Cancer Res, 56:1800-4 (1996).
22. J. P. Durham and D. H. Ives: Deoxycytidine kinase. I. Distribution in normal and neoplastic tissues and interrelationships of deoxycytidine and 1-beta-Darabinofuranosylcytosine phosphorylation. Mol Pharmacol, 5: 358-375 (1969).
23. B. A. Chabner, D. G. Johns, C. N. Coleman, J. C. Drake and W. H. Evans: Purification and properties of cytidine deaminase from normal and leukemic granulocytes. J Clin Invest, 53: 922-931 (1974).
24. D. W. Kufe, P. P. Major, E. M. Egan, G. P. Beardsley: Correlation of cytotoxicity with incorporation of ara-C into DNA. J Biol Chem, 255:8997-9990 (1980).
25. D. Kufe, D. Spriggs, E. M. Egan, D. Munroe: Relationships among Ara-CTP pools, formation of (Ara- C)DNA, and cytotoxicity of human leukemic cells. Blood, 64:54-8 (1984). (Pubitemid 14085726)
26. J. C. White, J. P. Rathmell and R. L. Cappizi: Membrane transport influences the rate of accumulation of cytosine arabinoside in human leukemia cells. J Clin Invest, 79: 380-387 (1987). (Pubitemid 17009669)
27. B. A. Chabner: Cytidine analogues. In: Cancer Chemotherapy and Biotherapy-Principles and Practice. Chabner BA and Longo DL (eds) Lippincott-Raven, Philadelphia, 213-234 (1996).
28. S. Watanabe and T. Uchida: Expression of cytidine deaminase in human solid tumors and its regulation by 1 alpha, 25- dihydroxyvitamin D3. Biochim Biophys Acta, 1312: 99-104 (1996). (Pubitemid 26227439)
29. G. Jahns-Streubel, C. Reuter, U. Auf der Landwehr, et al: Activity of thymidine kinase and of polymerase alpha as well as activity and gene expression of deoxycytidine deaminase in leukemic blasts are correlated with clinical response in the setting of granulocyte-macrophage colonystimulating factor-based priming before and during TAD-9 induction therapy in acute myeloid leukemia. Blood, 90: 1968-1976 (1997). (Pubitemid 27377308)
30. K. Walldén, P. Stenmark, T. Nyman, S. Flodin, S. Gräslund, P. Loppnau, et al: Crystal structure of human cytosolic 50-nucleotidase II: insights into allosteric regulation and substrate recognition. J Biol Chem, 282:17828-36 (2007). (Pubitemid 47100283)